Evaluation of the clinical inequivalency of drug products of varying bioavailability.
D000536:Aluminum Hydroxide; D001145:Arrhythmias, Cardiac / Q000097:blood / Q000188:drug therapy; D001702:Biopharmaceutics; D004077:Digoxin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005492:Folic Acid / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D010672:Phenytoin / Q000009:adverse effects / Q000378:metabolism; D012107:Research Design; D013752:Tetracycline / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D013810:Therapeutic Equivalency; D013997:Time Factors
D000536:Aluminum Hydroxide; D010672:Phenytoin; D004077:Digoxin; D005492:Folic Acid; D013752:Tetracycline